Iovance Biotherapeutics Inc (NASDAQ:IOVA)
| 22.25 Delayed Data As of Jan 24 |  -0.45 / -1.98%Today’s Change | 8.26 Today|||52-Week Range 29.68 | -19.62% Year-to-Date |
Latest IOVA News | Press Releases
| 2 Top Biotech Stocks to Buy Right Now Jan 23 / MotleyFool.com - Paid Partner Content | Why Iovance Biotherapeutics Shares Dropped 11.8% Today Jan 13 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 22.70 |
| Today’s open | 22.70 |
| Day’s range | 21.78 - 22.77 |
| Volume | 1,215,471 |
| Average volume (3 months) | 1,327,437 |
| Market cap | $2.8B |
Data as of 4:00pm ET, 01/24/2020
Growth & Valuation
| Earnings growth (last year) | +9.90% |
| Earnings growth (this year) | -17.95% |
| Earnings growth (next 5 years) | -19.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.89 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HALOHalozyme Therapeutic... | -0.59 | -3.03% |
| XLRNAcceleron Pharma Inc | -0.71 | -1.34% |
| ALLOAllogene Therapeutic... | -1.31 | -5.30% |
| KODKodiak Sciences Inc | -3.31 | -5.02% |
Data as of 4:00pm ET, 01/24/2020
Financials
| Next reporting date | March 6, 2020 |
| EPS forecast (this quarter) | -$0.42 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$123.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Carlos, California |
Forecasts
